Paying for Mental Health Care

Why Spravato Only Happens at Certified Centers

Save

Spravato can't be taken at home because it is dispensed only through a restricted program at certified centers, where you are supervised and monitored. That in-clinic rule also shapes billing: an observed, clinic-administered drug usually runs through your medical benefit rather than a pharmacy fill.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Continue in Claude

Open a chat with this article’s link already in the message, and keep asking questions there. Claude reads the article and its sources; nothing about you is included.

Continue in Claude →

The button opens the Claude desktop app and fills in the message for you to review before sending. No desktop app, or reading on a phone? Copy the prompt and paste it into any AI.

What does a certified center actually mean?

Certification is a controlled-access arrangement, not a mark of prestige. Esketamine is made available only through a restricted program, so it can be given and observed in enrolled healthcare settings rather than dispensed for you to use at home. In practice that means the medication is administered on site and you are monitored for a period before you leave. It is worth asking your prospective center to confirm how their program runs. Studies that describe real-world access to esketamine through insurance claims show how tightly delivery and eligibility are linked to these certified settings 1.

Why does in-clinic use change the bill?

Where a drug is given determines which benefit pays. A medication you pick up at a pharmacy usually runs through your pharmacy benefit, but a drug administered and monitored in a clinic is typically billed through the medical benefit, bundled with the visit and observation. That distinction is one reason Spravato coverage questions look different from ordinary prescription questions, and why value assessments modeled the treatment as a clinic-delivered course rather than a take-home pill 23. If you are budgeting, reading how Spravato is covered by insurance alongside what Spravato costs per session shows how the two sides connect.

How is this different from take-home antidepressants?

The contrast is the whole point. Most antidepressants are prescribed, filled at a pharmacy, and taken at home with periodic check-ins. Esketamine sits in a different category because it is given under supervision and you are observed afterward, which is why home use is not an option under the current program. That also means the logistics — a ride home, the observation window — become part of treatment, which we cover in getting home from a Spravato appointment. Seeing the two models side by side makes the restrictions feel less arbitrary and more like a design choice about how the drug is delivered.

Does the same rule apply to ketamine infusions?

Not identically, and the difference matters for coverage. Intravenous ketamine is also given in a clinic under monitoring, but it is used off-label, so it is often cash-pay rather than billed to insurance. Esketamine is the FDA-approved form delivered through the certified program, which is why it more often reaches a medical benefit. Research comparing the two on cost lays out how these delivery models diverge 3. If coverage is your deciding factor, comparing a ketamine clinic against Spravato coverage is a useful next read before you commit to either path.

When a prescriber helps you weigh the tradeoffs

A clinician who prescribes esketamine can explain what the certified-center requirement will mean for your week and your wallet. They can walk through the monitoring, confirm how their center bills, and tell you whether the in-clinic model fits your schedule and coverage or whether another option makes more sense. If you are still finding a program, SAMHSA's FindTreatment.gov can help you locate nearby options that accept your coverage 4. Gale can keep the coverage details, the appointment logistics, and your questions together, so the structure of treatment is clear before your first visit.

Common questions

Because it is available only through a restricted program at certified healthcare settings, where a clinician administers the dose and monitors you afterward. Home use is not part of the current program, so treatment happens on site. Confirm the specifics with your center 1.

Yes, indirectly. A drug administered and observed in a clinic is usually billed through your medical benefit rather than your pharmacy benefit, which is why Spravato coverage questions differ from ordinary prescription questions 23.

Not exactly. IV ketamine is also given in a monitored clinic setting, but it is used off-label and is often cash-pay, while esketamine is the FDA-approved form delivered through the certified program and more often billed to a medical benefit 3.

A prescriber can refer you, and SAMHSA's FindTreatment.gov locator can help you identify nearby programs 4. When you call, ask how their program is run and how they bill, so the logistics and coverage are clear before you start.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

If things feel heavy, a person is available anytime — call or text 988.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

If your symptoms escalate while you research options

  • —Thoughts of suicide or of harming yourself
  • —Feeling you cannot keep yourself safe
  • —A rapid worsening of depression or hopelessness
  • —New thoughts that you would be better off gone

This is general information about how esketamine is delivered, not medical advice, and program details can change. Confirm how your center administers and bills for treatment. If you are in crisis, you can reach the 988 Suicide & Crisis Lifeline by call or text, any time.

References

  1. 1.Zhdanava M et al. (2023). Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United States. Journal of Medical Economics. doi:10.1080/13696998.2023.2208993 ✓A U.S. claims-based description of esketamine treatment access and utilization, showing how real-world coverage and delivery patterns shape who receives it.
  2. 2.Agboola F et al. (2020). The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant Depression. Journal of Managed Care & Specialty Pharmacy (JMCP). doi:10.18553/jmcp.2020.26.1.16 ✓An ICER evidence report assessing the clinical effectiveness and value (including cost) of esketamine for treatment-resistant depression.
  3. 3.Brendle M et al. (2022). Cost-effectiveness of esketamine nasal spray compared to intravenous ketamine for patients with treatment-resistant depression in the US utilizing clinical trial efficacy and real-world effectiveness estimates. Journal of Affective Disorders. doi:10.1016/j.jad.2022.09.083 ✓A U.S. cost-effectiveness comparison of esketamine nasal spray versus intravenous ketamine for treatment-resistant depression.
  4. 4.Substance Abuse and Mental Health Services Administration (SAMHSA) (2025). FindTreatment.gov. Substance Abuse and Mental Health Services Administration. link ✓SAMHSA's confidential, anonymous locator for mental-health and substance-use treatment facilities, including those offering sliding-fee or low-cost care.

4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library